Results 231 to 240 of about 60,441 (347)

The Impact of Prolonged Exposure Therapy on Posttraumatic Stress Disorder Symptom Clusters in Adults Maintained on Medications for Opioid Use Disorder. [PDF]

Clin Psychol Psychother
Giannini JA, Badger GJ, Cole R, Peck KR.
europepmc   +1 more source

Moving Beyond Self-Report in Characterizing Drug Addiction: Using Drug-Biased Behavior to Predict Treatment Completion and Dropout in Heroin-Primary, Medication-Maintained Opioid Use Disorder

Natalie McClain, Ahmet O. Ceceli, Kim Drury, Greg Kronberg, Eric L. Garland, Nelly Alia‐Klein, Rita Z. Goldstein   +6 more
openalex   +1 more source

The role of NPs in medication-assisted treatment for opioid use disorder

, 2018
Brandi P. Cotton, Ginette G. Ferszt
openalex   +2 more sources

Outdated tools, underestimated harm: Modernizing cannabis surveillance in a post‐legalization era

Addiction, EarlyView.
Abstract Background Canada's 2018 legalization of non‐medical cannabis was positioned as a public health initiative, intended to shift cannabis use from criminalization to regulation. Since then, cannabis access and consumption have grown significantly but the systems used to monitor cannabis‐related harms have not kept pace.
Anees Bahji
wiley   +1 more source

Situational confidence and recovery capital among justice-involved adults receiving medications for opioid use disorder in a jail-based setting. [PDF]

Health Justice
Obekpa EO, He X, Betancur A, Gallardo KR, Rodriguez SA, McCurdy SA, Wilkerson JM.   +6 more
europepmc   +1 more source

Trends in Abstinence and Retention Associated with a Medication-Assisted Treatment Program for People with Opioid Use Disorders

, 2020
Kimberly D. Brunisholz, Andrew J. Knighton, Amulya Sharma, Lisa Nichols, Kristen Reisig, Jed Burton, Debbie Scovill, Carolyn Tometich, Mark Foote, Shelly Read, Scott Whittle   +10 more
openalex   +2 more sources

A cost–benefit analysis of the implementation and scale‐up of harm reduction interventions in the Australian Capital Territory

Addiction, EarlyView.
Abstract Background and aims Harm reduction interventions aim to reduce negative consequences of drug use. We aimed to estimate the cost, health impact and economic benefits of current, expanded and new harm reduction interventions for people who use drugs in the Australian Capital Territory.
Anna L. Bowring, Tom Tidhar, Anna Olsen, Christopher Bailie, Kelvin Burke, Rowan Martin‐Hughes, Helen Keane, Paul Dietze, Nick Scott   +8 more
wiley   +1 more source

Detecting cannabis use reduction through biochemical verification of urinary cannabinoids: An aggregated analysis of cannabis use disorder treatment trials examining average reductions and individual cut‐points

Addiction, EarlyView.
Abstract Background and aims Currently, there is no data‐driven cannabis reduction metric using biochemical verification, which represents a significant gap in cannabis harm reduction research, treatment and policy. Using aggregated data from 7 cannabis use disorder treatment trials, the aims of this analysis were to 1) determine if decreases in self ...
Erin A. McClure, Brian Neelon, Rachel L. Tomko, Ashley Dowd, Kevin M. Gray, Aimee L. McRae‐Clark, Nathaniel Baker   +6 more
wiley   +1 more source

Telemedicine to improve access to medications for opioid use disorder in Illinois, 2022-2024. [PDF]

Int J Drug Policy
Gressick K, Fiorillo M, Richardson S, Bruni M, Brenner S, Hua M, Prachand N, Gastala N.   +7 more
europepmc   +1 more source

Varenicline for cannabis use disorder: A randomized controlled trial

Addiction, EarlyView.
Abstract Background and aims Although cannabis use is widespread and prevalence of cannabis use disorder (CUD) is increasing, limited advancements have been made in CUD medication development. The objective of this study was to test the efficacy of varenicline with medical management for reducing cannabis use in treatment‐seeking individuals with CUD ...
Aimee L. McRae‐Clark, Kevin M. Gray, Nathaniel L. Baker, Brian J. Sherman, Bryan Tolliver, Jessica Burt, Alonzo Steplight, Elizabeth Chapman, Amanda Wagner   +8 more
wiley   +1 more source